.

ISSN 2063-5346
For urgent queries please contact : +918130348310

BENEFICIAL EFFECTS OF HYPOTHALAMIC PROLINE-RICH PEPTIDE-1 ON THE HEART FAILURE ASSOCIATED WITH EXPERIMENTAL PANCREATIC NECROSIS AND CRUSH SYNDROME

Main Article Content

A. G. Guevorkyan[a], N. Kh. Alchujyan[b]*, H. M. Mikayelyan[b], V. H. Barseghyan[b],H. L. Hayrapetyan[b], H. F. Khachatryan[b], V.S. Grigoryan[a], L. H. Melkonyan[c], S. G. Chailyan[b], G. A. Kevorkian
» doi: 10.17628/ECB.2016.5.259

Abstract

Hypothalamic neurosecretory cytokine, proline-rich peptide-1 (PRP-1) may protect against myocardial dysfunction and hypocalcemia induced by experimental pancreatic necrosis (PN) and/or crush syndrome (CS). 24 and 48 h after initiation of experimental PN, effective doses of PRP-1 were administered to adult Wistar male rats divided into groups corresponding to early, reparative, chronic, and chronic recurrent stages of PN. Similarly age and sex matched rats were immediately administered PRP-1 after 2 h of compression injury. The PRP-1 normalized the histopathological changes in cardiac tissues in the dynamics of both PN and CS. Study of 45Ca++ binding to the membrane proteins of cardiomyocyte sarcoplasmic reticulum (SR) showed that PRP-1 could prevent an impairment in the calcium binding ability of the Ca2+ depot proteins caused under pathological conditions. Besides, PRP-1 suppresses a PN and/or CS-induced compensatory manifestation the affinity to calcium of the 32-kDa SR membrane protein and restores its native properties. The results highlight new prospects over the functional implications of PRP-1 and its possible therapeutic potential for the treatment of patients at high risk of cardiovascular disease associated with different pathologies.

Article Details